Parnell may raise $5 million from public offering of ordinary stock

Bookrunner Ladenburg Thalmann helps finance general corporate purposes

By Devika Patel

Knoxville, Tenn., April 15 – Parnell Pharmaceuticals Holdings Ltd. will conduct a $5 million public sale of ordinary stock with a 30-day $750,000 greenshoe, according to a Form F-1 filed Friday with the Securities and Exchange Commission. The company has registered up to $5.75 million of stock.

Ladenburg Thalmann & Co. Inc. is the bookrunner.

Proceeds will be used for general corporate purposes and working capital requirements.

The animal health pharmaceutical company is based in Alexandria, Australia.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.